28/06/2014

Uso di rosiglitazone e rischio di carcinoma tiroideo

Rosiglitazone use in patients with type 2 diabetes may reduce the risk of thyroid cancer

 http://informahealthcare.com/doi/abs/10.3109/07853890.2013.851865 …

Condividi
Altri articoli